Rocket Pharmaceuticals Prices Public Offering of Common Stock

World News: . []

Rocket Pharmaceuticals Inc Nasdaq RCKT (“Rocket”), a leading US-based multi-platform gene therapy company today announces the pricing of an underwritten public offering of 4,500,000 shares of its common stock at a pu...

More news and information about Rocket Pharmaceuticals, Inc.

Published By:

Business Wire: 03:36 GMT Tuesday 16th April 2019

Published: .

Search for other references to "rocket" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us